nodes	percent_of_prediction	percent_of_DWPC	metapath
Dinoprostone—HPGDS—lung cancer	0.397	1	CbGaD
Dinoprostone—SLCO3A1—Methotrexate—lung cancer	0.0449	0.133	CbGbCtD
Dinoprostone—ABCC5—Cisplatin—lung cancer	0.0442	0.131	CbGbCtD
Dinoprostone—SLCO2B1—Erlotinib—lung cancer	0.0378	0.112	CbGbCtD
Dinoprostone—SLCO1C1—Methotrexate—lung cancer	0.0287	0.0852	CbGbCtD
Dinoprostone—CYP19A1—Paclitaxel—lung cancer	0.0242	0.0719	CbGbCtD
Dinoprostone—SLC22A7—Docetaxel—lung cancer	0.0195	0.058	CbGbCtD
Dinoprostone—SLCO1B1—Irinotecan—lung cancer	0.0176	0.0524	CbGbCtD
Dinoprostone—SLC22A2—Vinblastine—lung cancer	0.0169	0.0501	CbGbCtD
Dinoprostone—SLC22A2—Cisplatin—lung cancer	0.0155	0.0459	CbGbCtD
Dinoprostone—SLC22A11—Methotrexate—lung cancer	0.0148	0.044	CbGbCtD
Dinoprostone—PTGER4—pleura—lung cancer	0.0148	0.23	CbGeAlD
Dinoprostone—SLC22A7—Methotrexate—lung cancer	0.0141	0.0419	CbGbCtD
Dinoprostone—ABCC4—Methotrexate—lung cancer	0.0138	0.0409	CbGbCtD
Dinoprostone—SLCO1A2—Methotrexate—lung cancer	0.00989	0.0294	CbGbCtD
Dinoprostone—SLCO1B1—Methotrexate—lung cancer	0.00933	0.0277	CbGbCtD
Dinoprostone—SLC22A8—Methotrexate—lung cancer	0.00861	0.0256	CbGbCtD
Dinoprostone—CYP1A2—Erlotinib—lung cancer	0.0064	0.019	CbGbCtD
Dinoprostone—SLC22A6—Methotrexate—lung cancer	0.006	0.0178	CbGbCtD
Dinoprostone—PTGIR—pulmonary artery—lung cancer	0.0052	0.081	CbGeAlD
Dinoprostone—CYP1A2—Etoposide—lung cancer	0.00463	0.0137	CbGbCtD
Dinoprostone—PTGER3—mammary gland—lung cancer	0.00186	0.029	CbGeAlD
Dinoprostone—PTGER4—respiratory system—lung cancer	0.00147	0.0228	CbGeAlD
Dinoprostone—PTGER3—respiratory system—lung cancer	0.00124	0.0193	CbGeAlD
Dinoprostone—PTGER4—epithelium—lung cancer	0.00122	0.0191	CbGeAlD
Dinoprostone—PTGER4—bronchus—lung cancer	0.00121	0.0188	CbGeAlD
Dinoprostone—SLC51A—bronchus—lung cancer	0.00118	0.0185	CbGeAlD
Dinoprostone—Dinoprost Tromethamine—HPGDS—lung cancer	0.00117	0.771	CrCbGaD
Dinoprostone—PTGER2—trachea—lung cancer	0.0011	0.0172	CbGeAlD
Dinoprostone—HPGDS—respiratory system—lung cancer	0.00107	0.0167	CbGeAlD
Dinoprostone—SLC51B—lung—lung cancer	0.00107	0.0166	CbGeAlD
Dinoprostone—SLC51A—trachea—lung cancer	0.00106	0.0166	CbGeAlD
Dinoprostone—SLCO4A1—mammary gland—lung cancer	0.00106	0.0164	CbGeAlD
Dinoprostone—ABCC5—mammary gland—lung cancer	0.00105	0.0163	CbGeAlD
Dinoprostone—PTGFR—respiratory system—lung cancer	0.000992	0.0155	CbGeAlD
Dinoprostone—SLCO1B1—mammary gland—lung cancer	0.000928	0.0145	CbGeAlD
Dinoprostone—HPGDS—epithelium—lung cancer	0.000897	0.014	CbGeAlD
Dinoprostone—PTGER2—bone marrow—lung cancer	0.000875	0.0136	CbGeAlD
Dinoprostone—PTGIR—respiratory system—lung cancer	0.000875	0.0136	CbGeAlD
Dinoprostone—SLCO2B1—mammary gland—lung cancer	0.000821	0.0128	CbGeAlD
Dinoprostone—PTGFR—bronchus—lung cancer	0.000817	0.0127	CbGeAlD
Dinoprostone—PTGER2—lung—lung cancer	0.000793	0.0124	CbGeAlD
Dinoprostone—PTGER4—lung—lung cancer	0.000778	0.0121	CbGeAlD
Dinoprostone—SLC51A—lung—lung cancer	0.000765	0.0119	CbGeAlD
Dinoprostone—SLCO2A1—respiratory system—lung cancer	0.000764	0.0119	CbGeAlD
Dinoprostone—PTGFR—trachea—lung cancer	0.000733	0.0114	CbGeAlD
Dinoprostone—PTGIR—epithelium—lung cancer	0.000731	0.0114	CbGeAlD
Dinoprostone—PTGER3—lung—lung cancer	0.000659	0.0103	CbGeAlD
Dinoprostone—SLCO2A1—epithelium—lung cancer	0.000639	0.00995	CbGeAlD
Dinoprostone—SLCO3A1—bronchus—lung cancer	0.000635	0.00989	CbGeAlD
Dinoprostone—SLCO2A1—bronchus—lung cancer	0.000629	0.0098	CbGeAlD
Dinoprostone—HPGDS—bone marrow—lung cancer	0.000629	0.00979	CbGeAlD
Dinoprostone—SLCO4A1—bronchus—lung cancer	0.000579	0.00901	CbGeAlD
Dinoprostone—ABCC5—bronchus—lung cancer	0.000575	0.00896	CbGeAlD
Dinoprostone—HPGDS—lung—lung cancer	0.00057	0.00887	CbGeAlD
Dinoprostone—SLCO2A1—trachea—lung cancer	0.000565	0.0088	CbGeAlD
Dinoprostone—SLCO2B1—respiratory system—lung cancer	0.000547	0.00852	CbGeAlD
Dinoprostone—PTGER2—lymph node—lung cancer	0.000542	0.00845	CbGeAlD
Dinoprostone—SLCO3A1—cardiac atrium—lung cancer	0.000536	0.00835	CbGeAlD
Dinoprostone—PTGER4—lymph node—lung cancer	0.000532	0.00829	CbGeAlD
Dinoprostone—SLCO2A1—cardiac atrium—lung cancer	0.000531	0.00827	CbGeAlD
Dinoprostone—PTGFR—lung—lung cancer	0.000527	0.00821	CbGeAlD
Dinoprostone—SLC51A—lymph node—lung cancer	0.000523	0.00814	CbGeAlD
Dinoprostone—SLCO4A1—trachea—lung cancer	0.00052	0.00809	CbGeAlD
Dinoprostone—SLCO4A1—cardiac atrium—lung cancer	0.000488	0.0076	CbGeAlD
Dinoprostone—ABCC5—cardiac atrium—lung cancer	0.000485	0.00756	CbGeAlD
Dinoprostone—PTGIR—lung—lung cancer	0.000464	0.00723	CbGeAlD
Dinoprostone—PTGER3—lymph node—lung cancer	0.000451	0.00702	CbGeAlD
Dinoprostone—SLCO3A1—lung—lung cancer	0.00041	0.00638	CbGeAlD
Dinoprostone—ABCC5—bone marrow—lung cancer	0.00041	0.00638	CbGeAlD
Dinoprostone—SLCO2A1—lung—lung cancer	0.000406	0.00632	CbGeAlD
Dinoprostone—ABCC4—bronchus—lung cancer	0.000399	0.00621	CbGeAlD
Dinoprostone—HPGDS—lymph node—lung cancer	0.00039	0.00607	CbGeAlD
Dinoprostone—SLCO4A1—lung—lung cancer	0.000373	0.00582	CbGeAlD
Dinoprostone—ABCC5—lung—lung cancer	0.000371	0.00578	CbGeAlD
Dinoprostone—PTGFR—lymph node—lung cancer	0.00036	0.00561	CbGeAlD
Dinoprostone—Dihomo-gamma-linolenic acid—PTGS2—lung cancer	0.000346	0.229	CrCbGaD
Dinoprostone—CYP1A2—respiratory system—lung cancer	0.000329	0.00513	CbGeAlD
Dinoprostone—SLCO1C1—lymph node—lung cancer	0.000319	0.00496	CbGeAlD
Dinoprostone—PTGIR—lymph node—lung cancer	0.000318	0.00495	CbGeAlD
Dinoprostone—SLCO2B1—lung—lung cancer	0.000291	0.00453	CbGeAlD
Dinoprostone—ABCC4—bone marrow—lung cancer	0.000284	0.00442	CbGeAlD
Dinoprostone—SLCO3A1—lymph node—lung cancer	0.00028	0.00437	CbGeAlD
Dinoprostone—SLCO2A1—lymph node—lung cancer	0.000278	0.00432	CbGeAlD
Dinoprostone—CYP11A1—lymph node—lung cancer	0.000275	0.00428	CbGeAlD
Dinoprostone—SLCO1A2—lung—lung cancer	0.000267	0.00416	CbGeAlD
Dinoprostone—ABCC4—lung—lung cancer	0.000257	0.00401	CbGeAlD
Dinoprostone—SLCO4A1—lymph node—lung cancer	0.000255	0.00398	CbGeAlD
Dinoprostone—ABCC5—lymph node—lung cancer	0.000254	0.00395	CbGeAlD
Dinoprostone—SLCO2B1—lymph node—lung cancer	0.000199	0.0031	CbGeAlD
Dinoprostone—CYP19A1—lymph node—lung cancer	0.000178	0.00278	CbGeAlD
Dinoprostone—ABCC4—lymph node—lung cancer	0.000176	0.00274	CbGeAlD
Dinoprostone—CYP1A2—lung—lung cancer	0.000175	0.00272	CbGeAlD
Dinoprostone—Anaphylactic shock—Irinotecan—lung cancer	0.000128	0.00149	CcSEcCtD
Dinoprostone—Diarrhoea—Vinblastine—lung cancer	0.000127	0.00149	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Vinorelbine—lung cancer	0.000127	0.00148	CcSEcCtD
Dinoprostone—Back pain—Etoposide—lung cancer	0.000126	0.00147	CcSEcCtD
Dinoprostone—Shock—Irinotecan—lung cancer	0.000126	0.00147	CcSEcCtD
Dinoprostone—Tension—Paclitaxel—lung cancer	0.000125	0.00146	CcSEcCtD
Dinoprostone—Muscle spasms—Etoposide—lung cancer	0.000125	0.00146	CcSEcCtD
Dinoprostone—Anaphylactic shock—Gemcitabine—lung cancer	0.000124	0.00145	CcSEcCtD
Dinoprostone—Eye pain—Doxorubicin—lung cancer	0.000124	0.00145	CcSEcCtD
Dinoprostone—Diarrhoea—Topotecan—lung cancer	0.000124	0.00144	CcSEcCtD
Dinoprostone—Hyperhidrosis—Irinotecan—lung cancer	0.000123	0.00144	CcSEcCtD
Dinoprostone—Back pain—Paclitaxel—lung cancer	0.000123	0.00144	CcSEcCtD
Dinoprostone—Pharyngitis—Docetaxel—lung cancer	0.000123	0.00144	CcSEcCtD
Dinoprostone—Dizziness—Vinblastine—lung cancer	0.000123	0.00144	CcSEcCtD
Dinoprostone—Muscle spasms—Paclitaxel—lung cancer	0.000123	0.00143	CcSEcCtD
Dinoprostone—Diarrhoea—Erlotinib—lung cancer	0.000122	0.00143	CcSEcCtD
Dinoprostone—Abdominal pain—Vinorelbine—lung cancer	0.000122	0.00143	CcSEcCtD
Dinoprostone—Body temperature increased—Vinorelbine—lung cancer	0.000122	0.00143	CcSEcCtD
Dinoprostone—Myalgia—Cisplatin—lung cancer	0.000121	0.00141	CcSEcCtD
Dinoprostone—Vision blurred—Paclitaxel—lung cancer	0.00012	0.0014	CcSEcCtD
Dinoprostone—Hyperhidrosis—Gemcitabine—lung cancer	0.00012	0.0014	CcSEcCtD
Dinoprostone—Hot flush—Doxorubicin—lung cancer	0.00012	0.0014	CcSEcCtD
Dinoprostone—Dizziness—Topotecan—lung cancer	0.00012	0.0014	CcSEcCtD
Dinoprostone—Tremor—Paclitaxel—lung cancer	0.00012	0.00139	CcSEcCtD
Dinoprostone—Hypotension—Irinotecan—lung cancer	0.000119	0.00139	CcSEcCtD
Dinoprostone—Menopausal symptoms—Doxorubicin—lung cancer	0.000119	0.00139	CcSEcCtD
Dinoprostone—Vomiting—Vinblastine—lung cancer	0.000118	0.00138	CcSEcCtD
Dinoprostone—Dizziness—Erlotinib—lung cancer	0.000118	0.00138	CcSEcCtD
Dinoprostone—Headache—Vinblastine—lung cancer	0.000117	0.00136	CcSEcCtD
Dinoprostone—Hypotension—Gemcitabine—lung cancer	0.000116	0.00136	CcSEcCtD
Dinoprostone—Anaphylactic shock—Cisplatin—lung cancer	0.000116	0.00135	CcSEcCtD
Dinoprostone—Anaphylactoid reaction—Doxorubicin—lung cancer	0.000116	0.00135	CcSEcCtD
Dinoprostone—Flushing—Docetaxel—lung cancer	0.000115	0.00135	CcSEcCtD
Dinoprostone—Vomiting—Topotecan—lung cancer	0.000115	0.00134	CcSEcCtD
Dinoprostone—Paraesthesia—Irinotecan—lung cancer	0.000115	0.00134	CcSEcCtD
Dinoprostone—Syncope—Paclitaxel—lung cancer	0.000114	0.00134	CcSEcCtD
Dinoprostone—Loss of consciousness—Etoposide—lung cancer	0.000114	0.00133	CcSEcCtD
Dinoprostone—Rash—Topotecan—lung cancer	0.000114	0.00133	CcSEcCtD
Dinoprostone—Hypersensitivity—Vinorelbine—lung cancer	0.000114	0.00133	CcSEcCtD
Dinoprostone—Dermatitis—Topotecan—lung cancer	0.000114	0.00133	CcSEcCtD
Dinoprostone—Vomiting—Erlotinib—lung cancer	0.000114	0.00133	CcSEcCtD
Dinoprostone—Dyspnoea—Irinotecan—lung cancer	0.000114	0.00133	CcSEcCtD
Dinoprostone—Cough—Etoposide—lung cancer	0.000114	0.00132	CcSEcCtD
Dinoprostone—Headache—Topotecan—lung cancer	0.000113	0.00132	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.000113	0.00132	CcSEcCtD
Dinoprostone—Tachycardia—Cisplatin—lung cancer	0.000113	0.00132	CcSEcCtD
Dinoprostone—Rash—Erlotinib—lung cancer	0.000113	0.00132	CcSEcCtD
Dinoprostone—Dermatitis—Erlotinib—lung cancer	0.000113	0.00132	CcSEcCtD
Dinoprostone—Angiopathy—Docetaxel—lung cancer	0.000113	0.00132	CcSEcCtD
Dinoprostone—Hypertension—Etoposide—lung cancer	0.000112	0.00131	CcSEcCtD
Dinoprostone—Immune system disorder—Docetaxel—lung cancer	0.000112	0.00131	CcSEcCtD
Dinoprostone—Headache—Erlotinib—lung cancer	0.000112	0.00131	CcSEcCtD
Dinoprostone—Loss of consciousness—Paclitaxel—lung cancer	0.000112	0.00131	CcSEcCtD
Dinoprostone—Hyperhidrosis—Cisplatin—lung cancer	0.000112	0.00131	CcSEcCtD
Dinoprostone—Asthma—Methotrexate—lung cancer	0.000112	0.00131	CcSEcCtD
Dinoprostone—Paraesthesia—Gemcitabine—lung cancer	0.000112	0.0013	CcSEcCtD
Dinoprostone—Chills—Docetaxel—lung cancer	0.000111	0.0013	CcSEcCtD
Dinoprostone—Cough—Paclitaxel—lung cancer	0.000111	0.0013	CcSEcCtD
Dinoprostone—Asthenia—Vinorelbine—lung cancer	0.000111	0.0013	CcSEcCtD
Dinoprostone—Arrhythmia—Docetaxel—lung cancer	0.000111	0.00129	CcSEcCtD
Dinoprostone—Dyspnoea—Gemcitabine—lung cancer	0.000111	0.00129	CcSEcCtD
Dinoprostone—Chest pain—Etoposide—lung cancer	0.000111	0.00129	CcSEcCtD
Dinoprostone—Nausea—Vinblastine—lung cancer	0.000111	0.00129	CcSEcCtD
Dinoprostone—Hypertension—Paclitaxel—lung cancer	0.00011	0.00129	CcSEcCtD
Dinoprostone—Pain—Irinotecan—lung cancer	0.000109	0.00127	CcSEcCtD
Dinoprostone—Chest pain—Paclitaxel—lung cancer	0.000109	0.00127	CcSEcCtD
Dinoprostone—Arthralgia—Paclitaxel—lung cancer	0.000109	0.00127	CcSEcCtD
Dinoprostone—Myalgia—Paclitaxel—lung cancer	0.000109	0.00127	CcSEcCtD
Dinoprostone—Hypotension—Cisplatin—lung cancer	0.000108	0.00126	CcSEcCtD
Dinoprostone—Nausea—Topotecan—lung cancer	0.000107	0.00125	CcSEcCtD
Dinoprostone—Cardiac arrest—Doxorubicin—lung cancer	0.000107	0.00124	CcSEcCtD
Dinoprostone—Pain—Gemcitabine—lung cancer	0.000106	0.00124	CcSEcCtD
Dinoprostone—Nausea—Erlotinib—lung cancer	0.000106	0.00124	CcSEcCtD
Dinoprostone—Anaphylactic shock—Etoposide—lung cancer	0.000106	0.00124	CcSEcCtD
Dinoprostone—Diarrhoea—Vinorelbine—lung cancer	0.000106	0.00124	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000106	0.00123	CcSEcCtD
Dinoprostone—Back pain—Docetaxel—lung cancer	0.000105	0.00122	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Irinotecan—lung cancer	0.000104	0.00122	CcSEcCtD
Dinoprostone—Dehydration—Doxorubicin—lung cancer	0.000104	0.00122	CcSEcCtD
Dinoprostone—Anaphylactic shock—Paclitaxel—lung cancer	0.000104	0.00121	CcSEcCtD
Dinoprostone—Paraesthesia—Cisplatin—lung cancer	0.000104	0.00121	CcSEcCtD
Dinoprostone—Muscle spasms—Docetaxel—lung cancer	0.000104	0.00121	CcSEcCtD
Dinoprostone—Tachycardia—Etoposide—lung cancer	0.000104	0.00121	CcSEcCtD
Dinoprostone—Dyspnoea—Cisplatin—lung cancer	0.000103	0.00121	CcSEcCtD
Dinoprostone—Hyperhidrosis—Etoposide—lung cancer	0.000103	0.0012	CcSEcCtD
Dinoprostone—Shock—Paclitaxel—lung cancer	0.000102	0.0012	CcSEcCtD
Dinoprostone—Dizziness—Vinorelbine—lung cancer	0.000102	0.00119	CcSEcCtD
Dinoprostone—Tachycardia—Paclitaxel—lung cancer	0.000102	0.00119	CcSEcCtD
Dinoprostone—Body temperature increased—Irinotecan—lung cancer	0.000101	0.00118	CcSEcCtD
Dinoprostone—Abdominal pain—Irinotecan—lung cancer	0.000101	0.00118	CcSEcCtD
Dinoprostone—Hyperhidrosis—Paclitaxel—lung cancer	0.000101	0.00117	CcSEcCtD
Dinoprostone—Hypotension—Etoposide—lung cancer	9.92e-05	0.00116	CcSEcCtD
Dinoprostone—Pain—Cisplatin—lung cancer	9.91e-05	0.00116	CcSEcCtD
Dinoprostone—Vomiting—Vinorelbine—lung cancer	9.84e-05	0.00115	CcSEcCtD
Dinoprostone—Body temperature increased—Gemcitabine—lung cancer	9.83e-05	0.00115	CcSEcCtD
Dinoprostone—Rash—Vinorelbine—lung cancer	9.76e-05	0.00114	CcSEcCtD
Dinoprostone—Dermatitis—Vinorelbine—lung cancer	9.75e-05	0.00114	CcSEcCtD
Dinoprostone—Hypotension—Paclitaxel—lung cancer	9.73e-05	0.00114	CcSEcCtD
Dinoprostone—Headache—Vinorelbine—lung cancer	9.7e-05	0.00113	CcSEcCtD
Dinoprostone—Syncope—Docetaxel—lung cancer	9.7e-05	0.00113	CcSEcCtD
Dinoprostone—Asthma—Doxorubicin—lung cancer	9.68e-05	0.00113	CcSEcCtD
Dinoprostone—Paraesthesia—Etoposide—lung cancer	9.53e-05	0.00111	CcSEcCtD
Dinoprostone—Loss of consciousness—Docetaxel—lung cancer	9.5e-05	0.00111	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Paclitaxel—lung cancer	9.49e-05	0.00111	CcSEcCtD
Dinoprostone—Dyspnoea—Etoposide—lung cancer	9.47e-05	0.0011	CcSEcCtD
Dinoprostone—Cough—Docetaxel—lung cancer	9.44e-05	0.0011	CcSEcCtD
Dinoprostone—Hypersensitivity—Irinotecan—lung cancer	9.41e-05	0.0011	CcSEcCtD
Dinoprostone—Paraesthesia—Paclitaxel—lung cancer	9.35e-05	0.00109	CcSEcCtD
Dinoprostone—Hypertension—Docetaxel—lung cancer	9.34e-05	0.00109	CcSEcCtD
Dinoprostone—Dyspnoea—Paclitaxel—lung cancer	9.28e-05	0.00108	CcSEcCtD
Dinoprostone—Chest pain—Docetaxel—lung cancer	9.21e-05	0.00107	CcSEcCtD
Dinoprostone—Arthralgia—Docetaxel—lung cancer	9.21e-05	0.00107	CcSEcCtD
Dinoprostone—Myalgia—Docetaxel—lung cancer	9.21e-05	0.00107	CcSEcCtD
Dinoprostone—Nausea—Vinorelbine—lung cancer	9.19e-05	0.00107	CcSEcCtD
Dinoprostone—Body temperature increased—Cisplatin—lung cancer	9.16e-05	0.00107	CcSEcCtD
Dinoprostone—Asthenia—Irinotecan—lung cancer	9.16e-05	0.00107	CcSEcCtD
Dinoprostone—Pain—Etoposide—lung cancer	9.08e-05	0.00106	CcSEcCtD
Dinoprostone—Asthenia—Gemcitabine—lung cancer	8.92e-05	0.00104	CcSEcCtD
Dinoprostone—Pain—Paclitaxel—lung cancer	8.9e-05	0.00104	CcSEcCtD
Dinoprostone—Pharyngitis—Methotrexate—lung cancer	8.89e-05	0.00104	CcSEcCtD
Dinoprostone—Anaphylactic shock—Docetaxel—lung cancer	8.82e-05	0.00103	CcSEcCtD
Dinoprostone—Diarrhoea—Irinotecan—lung cancer	8.73e-05	0.00102	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Etoposide—lung cancer	8.68e-05	0.00101	CcSEcCtD
Dinoprostone—Shock—Docetaxel—lung cancer	8.68e-05	0.00101	CcSEcCtD
Dinoprostone—Tachycardia—Docetaxel—lung cancer	8.61e-05	0.00101	CcSEcCtD
Dinoprostone—Hypersensitivity—Cisplatin—lung cancer	8.54e-05	0.000997	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Paclitaxel—lung cancer	8.51e-05	0.000994	CcSEcCtD
Dinoprostone—Diarrhoea—Gemcitabine—lung cancer	8.51e-05	0.000993	CcSEcCtD
Dinoprostone—Dizziness—Irinotecan—lung cancer	8.44e-05	0.000985	CcSEcCtD
Dinoprostone—Abdominal pain—Etoposide—lung cancer	8.39e-05	0.00098	CcSEcCtD
Dinoprostone—Body temperature increased—Etoposide—lung cancer	8.39e-05	0.00098	CcSEcCtD
Dinoprostone—Asthenia—Cisplatin—lung cancer	8.32e-05	0.00097	CcSEcCtD
Dinoprostone—Hypotension—Docetaxel—lung cancer	8.25e-05	0.000962	CcSEcCtD
Dinoprostone—Abdominal pain—Paclitaxel—lung cancer	8.23e-05	0.00096	CcSEcCtD
Dinoprostone—Body temperature increased—Paclitaxel—lung cancer	8.23e-05	0.00096	CcSEcCtD
Dinoprostone—Angiopathy—Methotrexate—lung cancer	8.12e-05	0.000948	CcSEcCtD
Dinoprostone—Vomiting—Irinotecan—lung cancer	8.12e-05	0.000947	CcSEcCtD
Dinoprostone—Immune system disorder—Methotrexate—lung cancer	8.09e-05	0.000944	CcSEcCtD
Dinoprostone—Rash—Irinotecan—lung cancer	8.05e-05	0.000939	CcSEcCtD
Dinoprostone—Dermatitis—Irinotecan—lung cancer	8.04e-05	0.000938	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Docetaxel—lung cancer	8.04e-05	0.000938	CcSEcCtD
Dinoprostone—Chills—Methotrexate—lung cancer	8.03e-05	0.000937	CcSEcCtD
Dinoprostone—Headache—Irinotecan—lung cancer	8e-05	0.000933	CcSEcCtD
Dinoprostone—Diarrhoea—Cisplatin—lung cancer	7.93e-05	0.000925	CcSEcCtD
Dinoprostone—Paraesthesia—Docetaxel—lung cancer	7.92e-05	0.000925	CcSEcCtD
Dinoprostone—Vomiting—Gemcitabine—lung cancer	7.91e-05	0.000923	CcSEcCtD
Dinoprostone—Dyspnoea—Docetaxel—lung cancer	7.87e-05	0.000918	CcSEcCtD
Dinoprostone—Rash—Gemcitabine—lung cancer	7.84e-05	0.000915	CcSEcCtD
Dinoprostone—Dermatitis—Gemcitabine—lung cancer	7.83e-05	0.000914	CcSEcCtD
Dinoprostone—Hypersensitivity—Etoposide—lung cancer	7.82e-05	0.000913	CcSEcCtD
Dinoprostone—Headache—Gemcitabine—lung cancer	7.79e-05	0.000909	CcSEcCtD
Dinoprostone—Pharyngitis—Doxorubicin—lung cancer	7.69e-05	0.000898	CcSEcCtD
Dinoprostone—Hypersensitivity—Paclitaxel—lung cancer	7.67e-05	0.000895	CcSEcCtD
Dinoprostone—Asthenia—Etoposide—lung cancer	7.62e-05	0.000889	CcSEcCtD
Dinoprostone—Nausea—Irinotecan—lung cancer	7.58e-05	0.000885	CcSEcCtD
Dinoprostone—Pain—Docetaxel—lung cancer	7.55e-05	0.000881	CcSEcCtD
Dinoprostone—Back pain—Methotrexate—lung cancer	7.54e-05	0.00088	CcSEcCtD
Dinoprostone—Asthenia—Paclitaxel—lung cancer	7.47e-05	0.000872	CcSEcCtD
Dinoprostone—Nausea—Gemcitabine—lung cancer	7.39e-05	0.000862	CcSEcCtD
Dinoprostone—Vomiting—Cisplatin—lung cancer	7.37e-05	0.00086	CcSEcCtD
Dinoprostone—Vision blurred—Methotrexate—lung cancer	7.34e-05	0.000857	CcSEcCtD
Dinoprostone—Rash—Cisplatin—lung cancer	7.31e-05	0.000853	CcSEcCtD
Dinoprostone—Dermatitis—Cisplatin—lung cancer	7.3e-05	0.000852	CcSEcCtD
Dinoprostone—Diarrhoea—Etoposide—lung cancer	7.27e-05	0.000848	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Docetaxel—lung cancer	7.22e-05	0.000842	CcSEcCtD
Dinoprostone—Flushing—Doxorubicin—lung cancer	7.19e-05	0.00084	CcSEcCtD
Dinoprostone—Diarrhoea—Paclitaxel—lung cancer	7.12e-05	0.000831	CcSEcCtD
Dinoprostone—Angiopathy—Doxorubicin—lung cancer	7.03e-05	0.000821	CcSEcCtD
Dinoprostone—Dizziness—Etoposide—lung cancer	7.02e-05	0.000819	CcSEcCtD
Dinoprostone—Immune system disorder—Doxorubicin—lung cancer	7e-05	0.000817	CcSEcCtD
Dinoprostone—Abdominal pain—Docetaxel—lung cancer	6.98e-05	0.000814	CcSEcCtD
Dinoprostone—Body temperature increased—Docetaxel—lung cancer	6.98e-05	0.000814	CcSEcCtD
Dinoprostone—Chills—Doxorubicin—lung cancer	6.96e-05	0.000812	CcSEcCtD
Dinoprostone—Arrhythmia—Doxorubicin—lung cancer	6.93e-05	0.000808	CcSEcCtD
Dinoprostone—Dizziness—Paclitaxel—lung cancer	6.88e-05	0.000803	CcSEcCtD
Dinoprostone—Nausea—Cisplatin—lung cancer	6.88e-05	0.000803	CcSEcCtD
Dinoprostone—Cough—Methotrexate—lung cancer	6.8e-05	0.000794	CcSEcCtD
Dinoprostone—Vomiting—Etoposide—lung cancer	6.75e-05	0.000788	CcSEcCtD
Dinoprostone—Rash—Etoposide—lung cancer	6.7e-05	0.000781	CcSEcCtD
Dinoprostone—Dermatitis—Etoposide—lung cancer	6.69e-05	0.000781	CcSEcCtD
Dinoprostone—Headache—Etoposide—lung cancer	6.65e-05	0.000776	CcSEcCtD
Dinoprostone—Myalgia—Methotrexate—lung cancer	6.63e-05	0.000774	CcSEcCtD
Dinoprostone—Arthralgia—Methotrexate—lung cancer	6.63e-05	0.000774	CcSEcCtD
Dinoprostone—Chest pain—Methotrexate—lung cancer	6.63e-05	0.000774	CcSEcCtD
Dinoprostone—Tension—Doxorubicin—lung cancer	6.62e-05	0.000773	CcSEcCtD
Dinoprostone—Vomiting—Paclitaxel—lung cancer	6.62e-05	0.000773	CcSEcCtD
Dinoprostone—Rash—Paclitaxel—lung cancer	6.56e-05	0.000766	CcSEcCtD
Dinoprostone—Dermatitis—Paclitaxel—lung cancer	6.56e-05	0.000765	CcSEcCtD
Dinoprostone—Back pain—Doxorubicin—lung cancer	6.53e-05	0.000762	CcSEcCtD
Dinoprostone—Headache—Paclitaxel—lung cancer	6.52e-05	0.000761	CcSEcCtD
Dinoprostone—Hypersensitivity—Docetaxel—lung cancer	6.5e-05	0.000759	CcSEcCtD
Dinoprostone—Muscle spasms—Doxorubicin—lung cancer	6.49e-05	0.000757	CcSEcCtD
Dinoprostone—Anaphylactic shock—Methotrexate—lung cancer	6.36e-05	0.000742	CcSEcCtD
Dinoprostone—Vision blurred—Doxorubicin—lung cancer	6.36e-05	0.000742	CcSEcCtD
Dinoprostone—Asthenia—Docetaxel—lung cancer	6.33e-05	0.000739	CcSEcCtD
Dinoprostone—Nausea—Etoposide—lung cancer	6.31e-05	0.000736	CcSEcCtD
Dinoprostone—Nausea—Paclitaxel—lung cancer	6.18e-05	0.000722	CcSEcCtD
Dinoprostone—Hyperhidrosis—Methotrexate—lung cancer	6.15e-05	0.000718	CcSEcCtD
Dinoprostone—Syncope—Doxorubicin—lung cancer	6.05e-05	0.000706	CcSEcCtD
Dinoprostone—Diarrhoea—Docetaxel—lung cancer	6.04e-05	0.000705	CcSEcCtD
Dinoprostone—Hypotension—Methotrexate—lung cancer	5.94e-05	0.000694	CcSEcCtD
Dinoprostone—Loss of consciousness—Doxorubicin—lung cancer	5.93e-05	0.000692	CcSEcCtD
Dinoprostone—Cough—Doxorubicin—lung cancer	5.89e-05	0.000687	CcSEcCtD
Dinoprostone—Dizziness—Docetaxel—lung cancer	5.84e-05	0.000681	CcSEcCtD
Dinoprostone—Hypertension—Doxorubicin—lung cancer	5.83e-05	0.00068	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Methotrexate—lung cancer	5.79e-05	0.000676	CcSEcCtD
Dinoprostone—Myalgia—Doxorubicin—lung cancer	5.75e-05	0.00067	CcSEcCtD
Dinoprostone—Chest pain—Doxorubicin—lung cancer	5.75e-05	0.00067	CcSEcCtD
Dinoprostone—Arthralgia—Doxorubicin—lung cancer	5.75e-05	0.00067	CcSEcCtD
Dinoprostone—Paraesthesia—Methotrexate—lung cancer	5.71e-05	0.000666	CcSEcCtD
Dinoprostone—Dyspnoea—Methotrexate—lung cancer	5.67e-05	0.000662	CcSEcCtD
Dinoprostone—Vomiting—Docetaxel—lung cancer	5.61e-05	0.000655	CcSEcCtD
Dinoprostone—Rash—Docetaxel—lung cancer	5.56e-05	0.000649	CcSEcCtD
Dinoprostone—Dermatitis—Docetaxel—lung cancer	5.56e-05	0.000649	CcSEcCtD
Dinoprostone—Headache—Docetaxel—lung cancer	5.53e-05	0.000645	CcSEcCtD
Dinoprostone—Anaphylactic shock—Doxorubicin—lung cancer	5.51e-05	0.000643	CcSEcCtD
Dinoprostone—Pain—Methotrexate—lung cancer	5.44e-05	0.000635	CcSEcCtD
Dinoprostone—Shock—Doxorubicin—lung cancer	5.42e-05	0.000632	CcSEcCtD
Dinoprostone—Tachycardia—Doxorubicin—lung cancer	5.38e-05	0.000627	CcSEcCtD
Dinoprostone—Hyperhidrosis—Doxorubicin—lung cancer	5.32e-05	0.000621	CcSEcCtD
Dinoprostone—Nausea—Docetaxel—lung cancer	5.24e-05	0.000612	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Methotrexate—lung cancer	5.2e-05	0.000607	CcSEcCtD
Dinoprostone—Hypotension—Doxorubicin—lung cancer	5.15e-05	0.000601	CcSEcCtD
Dinoprostone—Abdominal pain—Methotrexate—lung cancer	5.03e-05	0.000587	CcSEcCtD
Dinoprostone—Body temperature increased—Methotrexate—lung cancer	5.03e-05	0.000587	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Doxorubicin—lung cancer	5.02e-05	0.000586	CcSEcCtD
Dinoprostone—Paraesthesia—Doxorubicin—lung cancer	4.95e-05	0.000577	CcSEcCtD
Dinoprostone—Dyspnoea—Doxorubicin—lung cancer	4.91e-05	0.000573	CcSEcCtD
Dinoprostone—Pain—Doxorubicin—lung cancer	4.71e-05	0.00055	CcSEcCtD
Dinoprostone—Hypersensitivity—Methotrexate—lung cancer	4.69e-05	0.000547	CcSEcCtD
Dinoprostone—Asthenia—Methotrexate—lung cancer	4.56e-05	0.000533	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Doxorubicin—lung cancer	4.5e-05	0.000526	CcSEcCtD
Dinoprostone—Abdominal pain—Doxorubicin—lung cancer	4.35e-05	0.000508	CcSEcCtD
Dinoprostone—Body temperature increased—Doxorubicin—lung cancer	4.35e-05	0.000508	CcSEcCtD
Dinoprostone—Diarrhoea—Methotrexate—lung cancer	4.35e-05	0.000508	CcSEcCtD
Dinoprostone—Dizziness—Methotrexate—lung cancer	4.21e-05	0.000491	CcSEcCtD
Dinoprostone—Hypersensitivity—Doxorubicin—lung cancer	4.06e-05	0.000474	CcSEcCtD
Dinoprostone—Vomiting—Methotrexate—lung cancer	4.04e-05	0.000472	CcSEcCtD
Dinoprostone—Rash—Methotrexate—lung cancer	4.01e-05	0.000468	CcSEcCtD
Dinoprostone—Dermatitis—Methotrexate—lung cancer	4.01e-05	0.000468	CcSEcCtD
Dinoprostone—Headache—Methotrexate—lung cancer	3.98e-05	0.000465	CcSEcCtD
Dinoprostone—Asthenia—Doxorubicin—lung cancer	3.95e-05	0.000461	CcSEcCtD
Dinoprostone—Nausea—Methotrexate—lung cancer	3.78e-05	0.000441	CcSEcCtD
Dinoprostone—Diarrhoea—Doxorubicin—lung cancer	3.77e-05	0.00044	CcSEcCtD
Dinoprostone—Dizziness—Doxorubicin—lung cancer	3.64e-05	0.000425	CcSEcCtD
Dinoprostone—Vomiting—Doxorubicin—lung cancer	3.5e-05	0.000409	CcSEcCtD
Dinoprostone—Rash—Doxorubicin—lung cancer	3.47e-05	0.000405	CcSEcCtD
Dinoprostone—Dermatitis—Doxorubicin—lung cancer	3.47e-05	0.000405	CcSEcCtD
Dinoprostone—Headache—Doxorubicin—lung cancer	3.45e-05	0.000403	CcSEcCtD
Dinoprostone—Nausea—Doxorubicin—lung cancer	3.27e-05	0.000382	CcSEcCtD
Dinoprostone—CYP19A1—Metabolism—ERCC2—lung cancer	3.74e-06	3.27e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—SRC—lung cancer	3.74e-06	3.27e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—KRAS—lung cancer	3.73e-06	3.26e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CXCL8—lung cancer	3.73e-06	3.26e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—MYC—lung cancer	3.73e-06	3.26e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—HRAS—lung cancer	3.7e-06	3.24e-05	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—IL6—lung cancer	3.7e-06	3.23e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—CAT—lung cancer	3.66e-06	3.2e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CXCL8—lung cancer	3.65e-06	3.19e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CXCL8—lung cancer	3.65e-06	3.19e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—EGFR—lung cancer	3.64e-06	3.19e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—HRAS—lung cancer	3.63e-06	3.17e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—HRAS—lung cancer	3.63e-06	3.17e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—STAT3—lung cancer	3.6e-06	3.15e-05	CbGpPWpGaD
Dinoprostone—PTGFR—GPCR downstream signaling—AKT1—lung cancer	3.6e-06	3.15e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—NRAS—lung cancer	3.6e-06	3.14e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GSTA3—lung cancer	3.59e-06	3.14e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—RRM1—lung cancer	3.59e-06	3.14e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—APOA1—lung cancer	3.58e-06	3.13e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—CYP1A1—lung cancer	3.57e-06	3.12e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CASP3—lung cancer	3.57e-06	3.12e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—IL2—lung cancer	3.56e-06	3.12e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—ABCB1—lung cancer	3.56e-06	3.11e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—IL6—lung cancer	3.55e-06	3.1e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—ERCC2—lung cancer	3.54e-06	3.1e-05	CbGpPWpGaD
Dinoprostone—PTGER1—GPCR downstream signaling—AKT1—lung cancer	3.53e-06	3.08e-05	CbGpPWpGaD
Dinoprostone—PTGIR—GPCR downstream signaling—AKT1—lung cancer	3.53e-06	3.08e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—GSTP1—lung cancer	3.5e-06	3.06e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—TYMS—lung cancer	3.49e-06	3.06e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CASP3—lung cancer	3.49e-06	3.05e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CASP3—lung cancer	3.49e-06	3.05e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—IL2—lung cancer	3.49e-06	3.05e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—IL2—lung cancer	3.49e-06	3.05e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CCND1—lung cancer	3.47e-06	3.04e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—IL6—lung cancer	3.47e-06	3.04e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—IL6—lung cancer	3.47e-06	3.04e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—JUN—lung cancer	3.47e-06	3.03e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—GSTM1—lung cancer	3.45e-06	3.02e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—MAPK3—lung cancer	3.44e-06	3.01e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—KRAS—lung cancer	3.44e-06	3.01e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.43e-06	3e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—PIK3CA—lung cancer	3.43e-06	3e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—PIK3CB—lung cancer	3.42e-06	2.99e-05	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—AKT1—lung cancer	3.41e-06	2.98e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—CAT—lung cancer	3.41e-06	2.98e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CCND1—lung cancer	3.4e-06	2.97e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CCND1—lung cancer	3.4e-06	2.97e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—JUN—lung cancer	3.39e-06	2.97e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—JUN—lung cancer	3.39e-06	2.97e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—PTGS2—lung cancer	3.39e-06	2.96e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—PTEN—lung cancer	3.37e-06	2.95e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—MMP9—lung cancer	3.37e-06	2.95e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—B4GALT5—lung cancer	3.37e-06	2.95e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CDKN1A—lung cancer	3.36e-06	2.94e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—PTEN—lung cancer	3.35e-06	2.93e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—MYC—lung cancer	3.35e-06	2.93e-05	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—AKT1—lung cancer	3.33e-06	2.91e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—TP53—lung cancer	3.32e-06	2.9e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—ABCB1—lung cancer	3.32e-06	2.9e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—MMP9—lung cancer	3.3e-06	2.89e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—MMP9—lung cancer	3.3e-06	2.89e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CDKN1A—lung cancer	3.29e-06	2.88e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CDKN1A—lung cancer	3.29e-06	2.88e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—PTEN—lung cancer	3.28e-06	2.87e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—PTEN—lung cancer	3.28e-06	2.87e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GSTA4—lung cancer	3.28e-06	2.87e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—EGFR—lung cancer	3.28e-06	2.86e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—CYP1A1—lung cancer	3.27e-06	2.86e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PIK3CG—lung cancer	3.27e-06	2.86e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—AKT1—lung cancer	3.27e-06	2.86e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—TYMS—lung cancer	3.26e-06	2.85e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—ERCC2—lung cancer	3.25e-06	2.84e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—APOA1—lung cancer	3.24e-06	2.83e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—GSTM1—lung cancer	3.22e-06	2.81e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—EP300—lung cancer	3.22e-06	2.81e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	3.21e-06	2.8e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—AKT1—lung cancer	3.2e-06	2.8e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—AKT1—lung cancer	3.2e-06	2.8e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—EP300—lung cancer	3.2e-06	2.8e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GSTA2—lung cancer	3.2e-06	2.8e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—HRAS—lung cancer	3.17e-06	2.77e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—PIK3CA—lung cancer	3.16e-06	2.77e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—EP300—lung cancer	3.13e-06	2.74e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—EP300—lung cancer	3.13e-06	2.74e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—POMC—lung cancer	3.11e-06	2.72e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—SRC—lung cancer	3.11e-06	2.72e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.1e-06	2.71e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—KRAS—lung cancer	3.09e-06	2.71e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GSTA1—lung cancer	3.08e-06	2.7e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—APOA1—lung cancer	3.06e-06	2.68e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—TP53—lung cancer	3.06e-06	2.68e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—CYP1A1—lung cancer	3.05e-06	2.67e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ABCC3—lung cancer	3.05e-06	2.67e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—SRC—lung cancer	3.04e-06	2.66e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—SRC—lung cancer	3.04e-06	2.66e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—IL6—lung cancer	3.04e-06	2.65e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—CREBBP—lung cancer	3.03e-06	2.65e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—VEGFA—lung cancer	3.03e-06	2.65e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—ERCC2—lung cancer	3.03e-06	2.65e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—STAT3—lung cancer	3e-06	2.62e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—NRAS—lung cancer	2.99e-06	2.62e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—VEGFA—lung cancer	2.96e-06	2.59e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—VEGFA—lung cancer	2.96e-06	2.59e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PIK3CG—lung cancer	2.96e-06	2.59e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—PTEN—lung cancer	2.96e-06	2.59e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—AKR1C1—lung cancer	2.95e-06	2.58e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—STAT3—lung cancer	2.94e-06	2.57e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—STAT3—lung cancer	2.94e-06	2.57e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.93e-06	2.57e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—NRAS—lung cancer	2.93e-06	2.56e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—NRAS—lung cancer	2.93e-06	2.56e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—HRAS—lung cancer	2.93e-06	2.56e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PIK3CD—lung cancer	2.88e-06	2.52e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—UGT1A1—lung cancer	2.87e-06	2.51e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—MAPK3—lung cancer	2.86e-06	2.51e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—PIK3CA—lung cancer	2.84e-06	2.49e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—ALB—lung cancer	2.84e-06	2.48e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—EP300—lung cancer	2.82e-06	2.47e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—POMC—lung cancer	2.82e-06	2.46e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—APOA1—lung cancer	2.81e-06	2.46e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—MAPK3—lung cancer	2.8e-06	2.45e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—MAPK3—lung cancer	2.8e-06	2.45e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—IL6—lung cancer	2.8e-06	2.45e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—AKT1—lung cancer	2.8e-06	2.45e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PIK3CG—lung cancer	2.8e-06	2.45e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—MYC—lung cancer	2.79e-06	2.44e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GNG11—lung cancer	2.76e-06	2.42e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	2.75e-06	2.41e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—CREBBP—lung cancer	2.74e-06	2.4e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—MYC—lung cancer	2.73e-06	2.39e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—MYC—lung cancer	2.73e-06	2.39e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—EGFR—lung cancer	2.73e-06	2.38e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—EGFR—lung cancer	2.67e-06	2.33e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—EGFR—lung cancer	2.67e-06	2.33e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—POMC—lung cancer	2.66e-06	2.33e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ALDOA—lung cancer	2.63e-06	2.3e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—HRAS—lung cancer	2.63e-06	2.3e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—APOA1—lung cancer	2.62e-06	2.29e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PIK3CD—lung cancer	2.6e-06	2.27e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—CREBBP—lung cancer	2.59e-06	2.27e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—AKT1—lung cancer	2.58e-06	2.26e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—KRAS—lung cancer	2.57e-06	2.25e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—ALB—lung cancer	2.57e-06	2.24e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PIK3CG—lung cancer	2.56e-06	2.24e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—NCOA3—lung cancer	2.56e-06	2.23e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—KRAS—lung cancer	2.52e-06	2.2e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—KRAS—lung cancer	2.52e-06	2.2e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—IL6—lung cancer	2.52e-06	2.2e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	2.51e-06	2.2e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PIK3CB—lung cancer	2.51e-06	2.19e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ADCY1—lung cancer	2.49e-06	2.17e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ABCG2—lung cancer	2.49e-06	2.17e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PTGS2—lung cancer	2.48e-06	2.17e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PIK3CD—lung cancer	2.46e-06	2.15e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—POMC—lung cancer	2.44e-06	2.13e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ENO2—lung cancer	2.44e-06	2.13e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—HPGDS—lung cancer	2.44e-06	2.13e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—ALB—lung cancer	2.43e-06	2.12e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PPP2R1B—lung cancer	2.42e-06	2.12e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	2.39e-06	2.09e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PIK3CG—lung cancer	2.39e-06	2.09e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—PIK3CA—lung cancer	2.38e-06	2.08e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—CREBBP—lung cancer	2.38e-06	2.08e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—PIK3CA—lung cancer	2.37e-06	2.07e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GSTT1—lung cancer	2.36e-06	2.07e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CYP2A6—lung cancer	2.34e-06	2.04e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GCLC—lung cancer	2.34e-06	2.04e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	2.33e-06	2.04e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—AKT1—lung cancer	2.32e-06	2.03e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—PIK3CA—lung cancer	2.32e-06	2.02e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—PIK3CA—lung cancer	2.32e-06	2.02e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—TP53—lung cancer	2.29e-06	2e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—POMC—lung cancer	2.27e-06	1.99e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PIK3CB—lung cancer	2.27e-06	1.98e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PIK3CD—lung cancer	2.25e-06	1.97e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PTGS2—lung cancer	2.25e-06	1.96e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—TP53—lung cancer	2.24e-06	1.96e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—TP53—lung cancer	2.24e-06	1.96e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—ALB—lung cancer	2.23e-06	1.95e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—CREBBP—lung cancer	2.22e-06	1.94e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ENO1—lung cancer	2.22e-06	1.94e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	2.21e-06	1.93e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—HRAS—lung cancer	2.19e-06	1.91e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	2.18e-06	1.91e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PTEN—lung cancer	2.17e-06	1.89e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PIK3CB—lung cancer	2.14e-06	1.88e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—HRAS—lung cancer	2.14e-06	1.87e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—HRAS—lung cancer	2.14e-06	1.87e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PTGS2—lung cancer	2.12e-06	1.86e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PIK3CD—lung cancer	2.1e-06	1.84e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—IL6—lung cancer	2.09e-06	1.83e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—PIK3CA—lung cancer	2.09e-06	1.82e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—ALB—lung cancer	2.07e-06	1.81e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—EP300—lung cancer	2.07e-06	1.81e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—IL6—lung cancer	2.05e-06	1.79e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—IL6—lung cancer	2.05e-06	1.79e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CYP2E1—lung cancer	1.99e-06	1.74e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—NQO1—lung cancer	1.96e-06	1.72e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PIK3CB—lung cancer	1.96e-06	1.72e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PTEN—lung cancer	1.96e-06	1.71e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PTGS2—lung cancer	1.95e-06	1.7e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—AKT1—lung cancer	1.95e-06	1.7e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—AKT1—lung cancer	1.93e-06	1.69e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.92e-06	1.68e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.91e-06	1.67e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—AKT1—lung cancer	1.89e-06	1.65e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—AKT1—lung cancer	1.89e-06	1.65e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—EP300—lung cancer	1.87e-06	1.63e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PTEN—lung cancer	1.85e-06	1.62e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PIK3CB—lung cancer	1.83e-06	1.6e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PTGS2—lung cancer	1.81e-06	1.59e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—STK11—lung cancer	1.77e-06	1.55e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—EP300—lung cancer	1.77e-06	1.55e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—AKT1—lung cancer	1.7e-06	1.49e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PTEN—lung cancer	1.7e-06	1.48e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.66e-06	1.45e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GSTP1—lung cancer	1.64e-06	1.43e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—EP300—lung cancer	1.62e-06	1.42e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CAT—lung cancer	1.59e-06	1.39e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.59e-06	1.39e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PTEN—lung cancer	1.58e-06	1.38e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ABCB1—lung cancer	1.55e-06	1.36e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PIK3CA—lung cancer	1.53e-06	1.34e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—TYMS—lung cancer	1.52e-06	1.33e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—EP300—lung cancer	1.51e-06	1.32e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GSTM1—lung cancer	1.51e-06	1.32e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CYP1A1—lung cancer	1.43e-06	1.25e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ERCC2—lung cancer	1.42e-06	1.24e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PIK3CA—lung cancer	1.38e-06	1.21e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PIK3CA—lung cancer	1.31e-06	1.14e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—AKT1—lung cancer	1.25e-06	1.09e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—APOA1—lung cancer	1.22e-06	1.07e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PIK3CA—lung cancer	1.2e-06	1.05e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.17e-06	1.03e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—AKT1—lung cancer	1.13e-06	9.87e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PIK3CG—lung cancer	1.12e-06	9.78e-06	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PIK3CA—lung cancer	1.12e-06	9.76e-06	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—AKT1—lung cancer	1.07e-06	9.34e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—POMC—lung cancer	1.06e-06	9.31e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CREBBP—lung cancer	1.04e-06	9.07e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PIK3CD—lung cancer	9.83e-07	8.6e-06	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—AKT1—lung cancer	9.78e-07	8.56e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ALB—lung cancer	9.7e-07	8.49e-06	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—AKT1—lung cancer	9.12e-07	7.98e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PIK3CB—lung cancer	8.57e-07	7.49e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PTGS2—lung cancer	8.49e-07	7.43e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PTEN—lung cancer	7.4e-07	6.48e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—EP300—lung cancer	7.06e-07	6.18e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PIK3CA—lung cancer	5.22e-07	4.57e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—AKT1—lung cancer	4.27e-07	3.73e-06	CbGpPWpGaD
